USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
DELPHINUS MEDICAL TECHNOLOGIES, INC.
Address:
46701 COMMERCE CENTER DR
PLYMOUTH, MI 48170-2475
Phone:
N/A
URL:
N/A
EIN:
127255576
DUNS:
963425017
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,142,304.00 2
SBIR Phase II $860,663.00 1

Award List:

Toward a practical ultrasound tomography algorithm for improved breast imaging

Award Year / Program / Phase:
2012 / SBIR / Phase I
Award Amount:
$137,554.00
Agency:
HHS
Principal Investigator:
Cuiping Li – 734-233-3088
Abstract:
DESCRIPTION (provided by applicant): Ultrasound tomography is an emerging modality for breast imaging. However, current ultrasonic tomography's imaging algorithms, hindered by the limited memory and processor speed of computers, are based on ray theory andassume a homogeneous background, which… More

Transitioning the SoftVue Breast Scanner to the clinical marketplace

Award Year / Program / Phase:
2012 / SBIR / Phase I
Award Amount:
$1,004,750.00
Agency:
HHS
Principal Investigator:
Nebojsa Duric – 313-670-5103
Abstract:
DESCRIPTION (provided by applicant): Mammography is the current cost-effective gold standard for breast cancer screening. However, its usefulness has recently become a subject of considerable debate. The limitations of mammography are most evident in the population of women who have dense breast… More

Transitioning the SoftVue Breast Scanner to the clinical marketplace

Award Year / Program / Phase:
2013 / SBIR / Phase II
Award Amount:
$860,663.00
Agency:
HHS
Principal Investigator:
Nebojsa Duric – 313-670-5103
Abstract:
DESCRIPTION (provided by applicant): Mammography is the current cost-effective gold standard for breast cancer screening. However, its usefulness has recently become a subject of considerable debate. The limitations of mammography are most evident in the population of women who have dense breast… More